A means of controlling the level and timing of expression of specific
genes in cultured cells or in animals would have broad applications. T
here has been recent progress in two very promising systems: problems
due to the high background expression from tetracycline-responsive pro
moters have been solved by constructing tetracycline-sensitive transcr
iptional repressors; and new rapamycin analogues have been isolated th
at are capable of activating the FK506-inducible system but lack the c
ytostatic side effects of the original inducers. Both systems now prov
ide opportunities for expressing toxic genes, growth arrest genes, and
therapeutic products in a regulated fashion previously not possible.